Please login to the form below

Not currently logged in
Email:
Password:

QuintilesIMS

This page shows the latest QuintilesIMS news and features for those working in and with pharma, biotech and healthcare.

QuintilesIMS changes its name to IQVIA

QuintilesIMS changes its name to IQVIA

Firm will focus on human data science solutions. A year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA. ... Bousbib added: “We launched as QuintilesIMS, then we built something transformational and that

Latest news

  • Teva faces early rival to longer-acting Copaxone in US Teva faces early rival to longer-acting Copaxone in US

    formulation making $700m in that period, according to QuintilesIMS data.

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by personalised medicines, particularly in oncology. ... There will be a full report on QuintilesIMS' Question

  • INC Research to merge with InVentiv Health INC Research to merge with InVentiv Health

    Combined will be second-largest outsourcing provider after QuintilesIMS. Contract research organisation INC Research and commercial services firm InVentiv Health are to combine to create the second largest biopharmaceutical outsourcing provider.

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    As QuintilesIMS’ report into the core challenge of multichannel marketing - Channel Preference Versus Promotional Reality - points out, the traditional sales rep model that has disappeared in many other industries remains strong

  • QuintilesIMS launches European oncology data-gathering initiative QuintilesIMS launches European oncology data-gathering initiative

    Will collaborate with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer. QuintilesIMS has teamed up with four big pharma firms to gather insights into the real-world use of oncology therapies ... Currently, treatment-use information in Europe is based

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics